Lemtrada
Multiple sclerosis drug Lemtrada has been found to have serious — even fatal — side effects which have led the European Medicines Agency (EMA) to temporarily restrict the drug’s use while an official review is ongoing. Lemtrada has been approved in the US for the treatment of MS since 2014….
